For your average midsize U.S. exporter, the protocol will likely have limited short-term implications — depending on what, exactly, the company does with its product.

Say, for example, the hypothetical company Bionic Peaches Inc. (BIP) processes some of its genetically altered fruit into juicy, dreamy jam here in the United States, then ships it to Tanzanian stores. Nothing changes under the protocol.